Sanofi Stock price

Equities

SAN

FR0000120578

Pharmaceuticals

Real-time Euronext Paris 12:35:32 2024-03-28 pm EDT 5-day change 1st Jan Change
90.96 EUR -0.87% Intraday chart for Sanofi +3.71% +1.34%
Sales 2024 * 46.44B 50.1B Sales 2025 * 50.22B 54.18B Capitalization 114B 123B
Net income 2024 * 7.34B 7.91B Net income 2025 * 8.67B 9.36B EV / Sales 2024 * 2.6 x
Net Debt 2024 * 6.96B 7.51B Net Debt 2025 * 2.43B 2.63B EV / Sales 2025 * 2.31 x
P/E ratio 2024 *
15.1 x
P/E ratio 2025 *
12.8 x
Employees 86,088
Yield 2024 *
4.22%
Yield 2025 *
4.57%
Free-Float 87.77%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.87%
1 week+3.71%
Current month+3.49%
1 month+2.39%
3 months+1.90%
6 months-9.73%
Current year+1.34%
More quotes
1 week
88.35
Extreme 88.35
92.04
1 month
86.20
Extreme 86.2
92.04
Current year
84.93
Extreme 84.93
96.50
1 year
80.60
Extreme 80.6
105.18
3 years
76.45
Extreme 76.45
106.66
5 years
67.65
Extreme 67.65
106.66
10 years
62.50
Extreme 62.5
106.66
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 19-08-31
Director of Finance/CFO 59 18-09-30
Chief Tech/Sci/R&D Officer - 16-08-31
Members of the board TitleAgeSince
Director/Board Member 70 14-04-30
Director/Board Member 62 20-04-27
Director/Board Member 64 20-05-21
More insiders
Date Price Change Volume
24-03-28 90.96 -0.87% 1,839,942
24-03-27 91.76 +0.50% 1,234,665
24-03-26 91.3 +1.84% 1,589,467
24-03-25 89.65 +1.13% 1,169,107
24-03-22 88.65 +1.07% 1,869,167

Real-time Euronext Paris, March 28, 2024 at 12:35 pm EDT

More quotes
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
90.96 EUR
Average target price
107.6 EUR
Spread / Average Target
+18.32%
Consensus
  1. Stock
  2. Equities
  3. Stock Sanofi - Euronext Paris